News Novo aims for GLP-1 sales growth in China Novo expects Victoza and semaglutide to gain momentum.
News Novo highlights key 'hypo' data from Tresiba at EASD Novo hopes data will justify higher price compared with rival.
News AZ talks up Bydureon data, GLP-1 and glucagon combo AstraZeneca is hoping new data showing its Bydureon diabetes drug cuts overall death risk could stave off competition from Novo Nordisk's potential next generation GLP-1 drug.
News Fitbit and Dexcom to bring diabetes data to Ionic smartwatch Dexcom G5 Mobile data will be displayed on Fitbit's Ionic smartwatch.
News FDA clears finger-prick free insulin pump-CGM combo Device combination capable of recommending treatment decisions without finger-pricking.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
